Hypophosphatemic Rickets in Norway

Haukeland University Hospital80 enrolled

Overview

The purpose of the study is to do a follow-up survey of all individuals with hereditary hypophosphatemia in Norway, focusing on manifestations in childhood and adolescence. The investigators also want to study phenotype-genotype associations, and look for new genes, in all forms of hereditary hypo and hyperphosphatemia.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Hypophosphatemia, Familial Rickets Hyperphosphatemia

Interventions

Alfacalcidol; phosphate.DIETARY_SUPPLEMENT

Individual dosage form and dosage depending on phenotype and underlying cause.

SevelamerDRUG

Pills. Individual dosage depending on clinical symptoms/phenotype.

Eligibility

Sex: ALLHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * All patients in the Norwegian population with hereditary hypophosphatemia, with or without rickets * Patients in the Norwegian population with hereditary hyperphosphatemia Exclusion Criteria: \-

Locations (1)

Haukeland University Hospital, Childrens departement

Bergen, Norway

Outcomes

Primary Outcomes

Growth

Change i height z-score from time of diagnosis to last registered consultation.

Time frame: Up to 18 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.